JACKSONVILLE, Fla.--(BUSINESS WIRE)--Cadre Holdings, Inc. (NYSE: CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced today its consolidated operating results for the three and nine months ended September 30, 2023.
- Net sales of $125.1 million for the third quarter; net sales of $357.9 million for the nine months ended September 30, 2023
- Gross profit margin of 42.8% for the third quarter; gross profit margin of 42.2% for the nine months ended September 30, 2023
- Net income of $11.1 million, or $0.29 per diluted share, for the third quarter; net income of $29.0 million, or $0.77 per diluted share, for the nine months ended September 30, 2023
- Adjusted EBITDA of $23.7 million for the third quarter; Adjusted EBITDA of $65.1 million for the nine months ended September 30, 2023
- Adjusted EBITDA margin of 19.0% for the third quarter; Adjusted EBITDA margin of 18.2% for the nine months ended September 30, 2023
- Declared quarterly cash dividend of $0.08 per share in October 2023
“Cadre’s outstanding third quarter is a testament to our team’s continued strategic execution, together with strong, sustained demand for our mission-critical safety and survivability equipment,” said Warren Kanders, CEO and Chairman. “The implementation of the Cadre operating model, focused on constant improvement and the optimization of outcomes, continued to drive our strong financial performance, highlighted by record Adjusted EBITDA margins and gross margins. For the second consecutive quarter, we achieved our highest Adjusted EBITDA in history, while generating increased net sales and net income both sequentially and year-over-year.”
Mr. Kanders added, “We are pleased to once again raise our full year Adjusted EBITDA outlook based on Cadre’s outperformance to date and confidence in our businesses’ fundamentals for the remainder of 2023. In both the US and internationally, we have seen a broad push to prioritize public safety and believe Cadre is ideally positioned to capitalize on these secular tailwinds over the medium and long term. We continue to actively pursue M&A opportunities to either enhance our market dominance or enter attractive, new adjacencies consistent with our key criteria. With entrenched positions in law enforcement, first responder and military markets, we are on pace to deliver record full year net sales in 2023 and remain excited about the opportunity to further grow our leading platform of premium safety brands moving forward.”
Third Quarter and Nine-Month 2023 Operating Results
For the quarter ended September 30, 2023, Cadre generated net sales of $125.1 million, as compared to $111.6 million for the quarter ended September 30, 2022. This increase was primarily the result of higher domestic demand for armor products and large international orders for crowd control products, partially offset by decreased agency demand for hard goods.
For the nine months ended September 30, 2023, Cadre generated net sales of $357.9 million, as compared to $334.2 million for the prior year period, mainly driven by recent acquisitions and higher demand for armor and crowd control products, partially offset by timing for our EOD products.
For the quarter ended September 30, 2023, Cadre generated gross profit of $53.6 million, as compared to $43.7 million for the quarter ended September 30, 2022. For the nine months ended September 30, 2023, Cadre generated gross profit of $151.0 million, as compared to $127.2 million for the prior year period.
Gross profit margin was 42.9% for the quarter ended September 30, 2023, as compared to 39.2% for the quarter ended September 30, 2022. Gross profit margin was 42.2% for the nine months ended September 30, 2023, as compared to 38.0% for the prior year period, mainly driven by favorable pricing and product mix, prior year amortization of inventory step-up related to acquisitions, and productivity, partially offset by inflation.
Net income was $11.1 million for the quarter ended September 30, 2023, as compared to a net income of $4.9 million for the quarter ended September 30, 2022. The increase resulted primarily from the change in year-over-year sales and the increase in gross profit margin.
Net income was $29.0 million for the nine months ended September 30, 2023, as compared to a net loss of $0.8 million for the prior year period, primarily due to the change in year-over-year sales, the increase in gross profit margin, and a decrease in stock-based compensation expense.
Cadre generated $23.7 million of Adjusted EBITDA for the quarter ended September 30, 2023, as compared to $20.7 million for the quarter ended September 30, 2022. Adjusted EBITDA margin was 19.0% for the quarter ended September 30, 2023, as compared to 18.6% for the prior year period.
Cadre generated $65.1 million of Adjusted EBITDA for the nine months ended September 30, 2023, as compared to $53.3 million for the prior year period. Adjusted EBITDA margin was 18.2% for the nine months ended September 30, 2023, as compared to 16.0% for the prior year period.
Product segment gross margin was 44.3% and 43.9% for the third quarter and first nine months of 2023, respectively, compared to 41.6% and 40.2% for the respective prior year periods.
Distribution segment gross margin was 22.7% and 23.3% for the third quarter and first nine months of 2023, respectively, compared to 19.8% and 20.9% for the respective prior year periods.
Liquidity, Cash Flows and Capital Allocation
- Cash and cash equivalents increased by $24.1 million from $45.3 million as of December 31, 2022 to $69.4 million as of September 30, 2023.
- Total debt decreased by $6.1 million from $149.7 million as of December 31, 2022, to $143.6 million as of September 30, 2023.
- Net debt (total debt net of cash and cash equivalents) decreased by $30.3 million from $104.4 million as of December 31, 2022, to $74.2 million as of September 30, 2023.
- Capital expenditures totaled $1.8 million for the third quarter and $4.3 million for the nine months ended September 30, 2023, compared with $0.7 million for the third quarter and $3.2 million for the nine months ended September 30, 2022.
Dividend
On October 24, 2023, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.08 per share, or $0.32 per share on an annualized basis. Cadre's dividend payment will be made on November 17, 2023, to shareholders of record as of the close of business on the record date of November 3, 2023. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors.
2023 Outlook Update
As a result of the Company's third-quarter performance and management's outlook for the remainder of the year, Cadre raised the midpoint of its full-year Adjusted EBITDA guidance range and increased net sales guidance. For the full year 2023, Cadre expects to generate net sales in the range of $477 million to $481 million and Adjusted EBITDA in the range of $82 million to $85 million. We expect capital expenditures to be in the range of $7.0 million to $8.0 million.
Conference Call
Cadre management will host a conference call on Wednesday, November 8, 2023, at 5:00 PM EST to discuss the latest corporate developments and financial results. The dial-in number for callers in the US is (888)-510-2553 and the dial-in number for international callers is 646-960-0473. The access code for all callers is 1410384. A live webcast will also be available on the Company’s website at https://www.cadre-holdings.com/.
A replay of the call will be available through November 22, 2023. To access the replay, please dial 800-770-2030 in the U.S. or +1-647-362-9199 if outside the U.S., and then enter the access code 1410384.
About Cadre
Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety and survivability products for first responders. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, and duty gear. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland® and Med-Eng®, amongst others.
Use of Non-GAAP Measures
The Company reports its financial results in accordance with U.S. generally accepted accounting principles (“GAAP”). The press release contains the non-GAAP measures: (i) earnings before interest, taxes, other income or expense, depreciation and amortization (“EBITDA”), (ii) adjusted EBITDA, (iii) adjusted EBITDA margin and (iv) last twelve months adjusted EBITDA. The Company believes the presentation of these non-GAAP measures provides useful information for the understanding of its ongoing operations and enables investors to focus on period- over-period operating performance, and thereby enhances the user’s overall understanding of the Company’s current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company’s reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.
Forward-Looking Statements
Except for historical information, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include but are not limited to all projections and anticipated levels of future performance. Forward-looking statements involve risks, uncertainties and other factors that may cause our actual results to differ materially from those discussed herein. Any number of factors could cause actual results to differ materially from projections or forward-looking statements, including without limitation, changes to global, social and political economic conditions, spending patterns of government agencies, competitive pressures, the impact of acquisitions and related integration activities, logistical challenges related to disruptions and delays, product liability claims, the success of new product introductions, currency exchange rate fluctuations and the risks of doing business in the markets in which we operate, including foreign countries. More information on potential factors that could affect the Company’s financial results are more fully described from time to time in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release, and speak only as of the date hereof. We assume no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release.
CADRE HOLDINGS, INC. |
||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||||
(Unaudited) |
||||||||
(In thousands, except share and per share amounts) |
||||||||
|
|
|
|
|
|
|
||
|
|
September 30, 2023 |
|
December 31, 2022 |
||||
Assets |
|
|
|
|
|
|
||
Current assets |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
69,412 |
|
|
$ |
45,286 |
|
Accounts receivable, net of allowance for doubtful accounts of $819 and $924, respectively |
|
|
61,261 |
|
|
|
64,557 |
|
Inventories |
|
|
82,546 |
|
|
|
70,273 |
|
Prepaid expenses |
|
|
14,667 |
|
|
|
10,091 |
|
Other current assets |
|
|
8,836 |
|
|
|
6,811 |
|
Total current assets |
|
|
236,722 |
|
|
|
197,018 |
|
Property and equipment, net of accumulated depreciation and amortization of $48,994 and $42,694, respectively |
|
|
43,657 |
|
|
|
45,285 |
|
Operating lease assets |
|
|
6,643 |
|
|
|
8,489 |
|
Deferred tax assets, net |
|
|
2,299 |
|
|
|
2,255 |
|
Intangible assets, net |
|
|
44,333 |
|
|
|
50,695 |
|
Goodwill |
|
|
81,212 |
|
|
|
81,576 |
|
Other assets |
|
|
5,639 |
|
|
|
6,634 |
|
Total assets |
|
$ |
420,505 |
|
|
$ |
391,952 |
|
|
|
|
|
|
|
|
||
Liabilities, Mezzanine Equity and Shareholders' Equity |
|
|
|
|
|
|
||
Current liabilities |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
30,733 |
|
|
$ |
23,406 |
|
Accrued liabilities |
|
|
38,673 |
|
|
|
38,720 |
|
Income tax payable |
|
|
7,049 |
|
|
|
4,584 |
|
Liabilities held for sale |
|
|
— |
|
|
|
— |
|
Current portion of long-term debt |
|
|
13,251 |
|
|
|
12,211 |
|
Total current liabilities |
|
|
89,706 |
|
|
|
78,921 |
|
Long-term debt |
|
|
130,309 |
|
|
|
137,476 |
|
Long-term operating lease liabilities |
|
|
3,603 |
|
|
|
4,965 |
|
Deferred tax liabilities |
|
|
5,047 |
|
|
|
3,508 |
|
Other liabilities |
|
|
1,843 |
|
|
|
1,192 |
|
Total liabilities |
|
|
230,508 |
|
|
|
226,062 |
|
|
|
|
|
|
|
|
||
Mezzanine equity |
|
|
|
|
|
|
||
Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2023 and December 31, 2022) |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
||
Shareholders' equity |
|
|
|
|
|
|
||
Common stock ($0.0001 par value, 190,000,000 shares authorized, 37,586,031 and 37,332,271 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively) |
|
|
4 |
|
|
|
4 |
|
Additional paid-in capital |
|
|
210,543 |
|
|
|
206,540 |
|
Accumulated other comprehensive income |
|
|
2,143 |
|
|
|
2,087 |
|
Accumulated deficit |
|
|
(22,693 |
) |
|
|
(42,741 |
) |
Total shareholders’ equity |
|
|
189,997 |
|
|
|
165,890 |
|
Total liabilities, mezzanine equity and shareholders' equity |
|
$ |
420,505 |
|
|
$ |
391,952 |
|
CADRE HOLDINGS, INC. |
||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||||||||||
(Unaudited) |
||||||||||||||||
(In thousands, except share and per share amounts) |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
||||||||||||
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
||||||||
Net sales |
|
$ |
125,114 |
|
|
$ |
111,554 |
|
|
$ |
357,949 |
|
|
$ |
334,192 |
|
Cost of goods sold |
|
|
71,511 |
|
|
|
67,814 |
|
|
|
206,981 |
|
|
|
207,042 |
|
Gross profit |
|
|
53,603 |
|
|
|
43,740 |
|
|
|
150,968 |
|
|
|
127,150 |
|
Operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Selling, general and administrative |
|
|
36,314 |
|
|
|
31,732 |
|
|
|
105,615 |
|
|
|
118,431 |
|
Restructuring and transaction costs |
|
|
439 |
|
|
|
1,578 |
|
|
|
1,132 |
|
|
|
3,380 |
|
Related party expense |
|
|
116 |
|
|
|
112 |
|
|
|
379 |
|
|
|
1,346 |
|
Total operating expenses |
|
|
36,869 |
|
|
|
33,422 |
|
|
|
107,126 |
|
|
|
123,157 |
|
Operating income |
|
|
16,734 |
|
|
|
10,318 |
|
|
|
43,842 |
|
|
|
3,993 |
|
Other expense |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Interest expense |
|
|
(1,073 |
) |
|
|
(1,567 |
) |
|
|
(3,727 |
) |
|
|
(4,496 |
) |
Other (expense) income, net |
|
|
(315 |
) |
|
|
(1,851 |
) |
|
|
395 |
|
|
|
(2,812 |
) |
Total other expense, net |
|
|
(1,388 |
) |
|
|
(3,418 |
) |
|
|
(3,332 |
) |
|
|
(7,308 |
) |
Income (loss) before provision for income taxes |
|
|
15,346 |
|
|
|
6,900 |
|
|
|
40,510 |
|
|
|
(3,315 |
) |
(Provision) benefit for income taxes |
|
|
(4,293 |
) |
|
|
(1,959 |
) |
|
|
(11,463 |
) |
|
|
2,536 |
|
Net income (loss) |
|
$ |
11,053 |
|
|
$ |
4,941 |
|
|
$ |
29,047 |
|
|
$ |
(779 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
$ |
0.29 |
|
|
$ |
0.13 |
|
|
$ |
0.77 |
|
|
$ |
(0.02 |
) |
Diluted |
|
$ |
0.29 |
|
|
$ |
0.13 |
|
|
$ |
0.77 |
|
|
$ |
(0.02 |
) |
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
|
37,586,031 |
|
|
|
37,289,880 |
|
|
|
37,515,976 |
|
|
|
35,697,891 |
|
Diluted |
|
|
37,930,888 |
|
|
|
37,747,614 |
|
|
|
37,830,790 |
|
|
|
35,697,891 |
|
CADRE HOLDINGS, INC. |
||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||||||
(Unaudited) |
||||||||
(In thousands) |
||||||||
|
|
|
|
|
|
|
||
|
|
Nine Months Ended September 30, |
||||||
|
|
2023 |
|
2022 |
||||
Cash Flows From Operating Activities: |
|
|
|
|
|
|
||
Net income (loss) |
|
$ |
29,047 |
|
|
$ |
(779 |
) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
|
|
|
|
|
|
||
Depreciation and amortization |
|
|
12,385 |
|
|
|
11,319 |
|
Amortization of original issue discount and debt issue costs |
|
|
359 |
|
|
|
554 |
|
Amortization of inventory step-up |
|
|
— |
|
|
|
3,055 |
|
Deferred income taxes |
|
|
1,317 |
|
|
|
(2,755 |
) |
Stock-based compensation |
|
|
7,060 |
|
|
|
28,988 |
|
Gain on sale of fixed assets |
|
|
(98 |
) |
|
|
— |
|
Provision for losses on accounts receivable |
|
|
37 |
|
|
|
245 |
|
Foreign exchange (gain) loss |
|
|
(243 |
) |
|
|
3,006 |
|
Other |
|
|
(296 |
) |
|
|
— |
|
Changes in operating assets and liabilities, net of impact of acquisitions: |
|
|
|
|
|
|
||
Accounts receivable |
|
|
3,429 |
|
|
|
(3,271 |
) |
Inventories |
|
|
(12,229 |
) |
|
|
(7,187 |
) |
Prepaid expenses and other assets |
|
|
(3,131 |
) |
|
|
986 |
|
Accounts payable and other liabilities |
|
|
8,623 |
|
|
|
(4,660 |
) |
Net cash provided by operating activities |
|
|
46,260 |
|
|
|
29,501 |
|
Cash Flows From Investing Activities: |
|
|
|
|
|
|
||
Purchase of property and equipment |
|
|
(4,248 |
) |
|
|
(2,938 |
) |
Proceeds from disposition of property and equipment |
|
|
206 |
|
|
|
— |
|
Business acquisitions, net of cash acquired |
|
|
— |
|
|
|
(55,039 |
) |
Net cash used in investing activities |
|
|
(4,042 |
) |
|
|
(57,977 |
) |
Cash Flows From Financing Activities: |
|
|
|
|
|
|
||
Proceeds from revolving credit facilities |
|
|
— |
|
|
|
43,000 |
|
Principal payments on revolving credit facilities |
|
|
— |
|
|
|
(43,000 |
) |
Principal payments on term loans |
|
|
(7,500 |
) |
|
|
(7,514 |
) |
Proceeds from insurance premium financing |
|
|
3,949 |
|
|
|
3,989 |
|
Principal payments on insurance premium financing |
|
|
(2,909 |
) |
|
|
(3,878 |
) |
Payment of capital leases |
|
|
— |
|
|
|
(26 |
) |
Taxes paid in connection with employee stock transactions |
|
|
(2,725 |
) |
|
|
(6,216 |
) |
Proceeds from secondary offering, net of underwriter discounts |
|
|
— |
|
|
|
56,329 |
|
Deferred offering costs |
|
|
— |
|
|
|
(2,953 |
) |
Dividends distributed |
|
|
(8,999 |
) |
|
|
(8,521 |
) |
Net cash (used in) provided by financing activities |
|
|
(18,184 |
) |
|
|
31,210 |
|
Effect of foreign exchange rates on cash and cash equivalents |
|
|
92 |
|
|
|
(241 |
) |
Change in cash and cash equivalents |
|
|
24,126 |
|
|
|
2,493 |
|
Cash and cash equivalents, beginning of period |
|
|
45,286 |
|
|
|
33,857 |
|
Cash and cash equivalents, end of period |
|
$ |
69,412 |
|
|
$ |
36,350 |
|
Supplemental Disclosure of Cash Flows Information: |
|
|
|
|
|
|
||
Cash paid for income taxes, net |
|
$ |
7,923 |
|
|
$ |
710 |
|
Cash paid for interest |
|
$ |
7,389 |
|
|
$ |
3,860 |
|
Supplemental Disclosure of Non-Cash Investing and Financing Activities: |
|
|
|
|
|
|
||
Accruals and accounts payable for capital expenditures |
|
$ |
24 |
|
|
$ |
272 |
|
CADRE HOLDINGS, INC. |
|||||||||||||
SEGMENT INFORMATION |
|||||||||||||
(Unaudited) |
|||||||||||||
(In thousands) |
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, 2023 |
|||||||||||
|
|
|
|
|
|
|
|
Reconciling |
|
|
|
||
|
|
Product |
|
Distribution |
|
Items(1) |
|
Total |
|||||
Net sales |
|
$ |
108,495 |
|
$ |
24,208 |
|
$ |
(7,589 |
) |
|
$ |
125,114 |
Cost of goods sold |
|
|
60,380 |
|
|
18,724 |
|
|
(7,593 |
) |
|
|
71,511 |
Gross profit |
|
$ |
48,115 |
|
$ |
5,484 |
|
$ |
4 |
|
|
$ |
53,603 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, 2022 |
|||||||||||
|
|
|
|
|
|
|
|
Reconciling |
|
|
|
||
|
|
Product |
|
Distribution |
|
Items(1) |
|
Total |
|||||
Net sales |
|
$ |
92,718 |
|
$ |
26,012 |
|
$ |
(7,176 |
) |
|
$ |
111,554 |
Cost of goods sold |
|
|
54,125 |
|
|
20,859 |
|
|
(7,170 |
) |
|
|
67,814 |
Gross profit |
|
$ |
38,593 |
|
$ |
5,153 |
|
$ |
(6 |
) |
|
$ |
43,740 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2023 |
|||||||||||
|
|
|
|
|
|
|
|
Reconciling |
|
|
|
||
|
|
Product |
|
Distribution |
|
Items(1) |
|
Total |
|||||
Net sales |
|
$ |
305,057 |
|
$ |
74,594 |
|
$ |
(21,702 |
) |
|
$ |
357,949 |
Cost of goods sold |
|
|
171,204 |
|
|
57,200 |
|
|
(21,423 |
) |
|
|
206,981 |
Gross profit |
|
$ |
133,853 |
|
$ |
17,394 |
|
$ |
(279 |
) |
|
$ |
150,968 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2022 |
|||||||||||
|
|
|
|
|
|
|
|
Reconciling |
|
|
|
||
|
|
Product |
|
Distribution |
|
Items(1) |
|
Total |
|||||
Net sales |
|
$ |
277,941 |
|
$ |
73,836 |
|
$ |
(17,585 |
) |
|
$ |
334,192 |
Cost of goods sold |
|
|
166,192 |
|
58,437 |
|
(17,587 |
) |
|
|
207,042 |
||
Gross profit |
|
$ |
111,749 |
|
$ |
15,399 |
|
$ |
2 |
|
|
$ |
127,150 |
_________________ | ||
(1) | Reconciling items consist primarily of intercompany eliminations and items not directly attributable to operating segments. |
CADRE HOLDINGS, INC. |
||||||||||||||||||||||||||||
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES |
||||||||||||||||||||||||||||
(Unaudited) |
||||||||||||||||||||||||||||
(In thousands) |
||||||||||||||||||||||||||||
|
|
Year ended |
|
Three Months |
|
Three Months Ended |
|
Nine Months Ended |
|
Last Twelve |
||||||||||||||||||
|
|
December 31, |
|
Ended June 30, |
|
September 30, |
|
September 30, |
|
Months |
||||||||||||||||||
|
|
2022 |
|
2023 |
|
2023 |
|
|
2022 |
|
|
2023 |
|
2022 |
|
September 30, 2023 |
||||||||||||
Net income (loss) |
|
$ |
5,820 |
|
|
$ |
10,992 |
|
|
$ |
11,053 |
|
$ |
4,941 |
|
$ |
29,047 |
|
|
$ |
(779 |
) |
|
$ |
35,646 |
|
||
Add back: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Depreciation and amortization |
|
|
15,651 |
|
|
|
3,959 |
|
|
|
4,165 |
|
|
3,939 |
|
|
12,385 |
|
|
|
11,319 |
|
|
|
16,717 |
|
||
Interest expense |
|
|
6,206 |
|
|
|
1,013 |
|
|
|
1,073 |
|
|
1,567 |
|
|
3,727 |
|
|
|
4,496 |
|
|
|
5,437 |
|
||
Provision (benefit) for income taxes |
|
|
3,553 |
|
|
|
4,229 |
|
|
|
4,293 |
|
|
1,959 |
|
|
11,463 |
|
|
|
(2,536 |
) |
|
|
17,552 |
|
||
EBITDA |
|
$ |
31,230 |
|
|
$ |
20,193 |
|
|
$ |
20,584 |
|
$ |
12,406 |
|
$ |
56,622 |
|
|
$ |
12,500 |
|
|
$ |
75,352 |
|
||
Add back: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Restructuring and transaction costs(1) |
|
|
5,355 |
|
|
|
693 |
|
|
|
439 |
|
|
1,578 |
|
|
1,132 |
|
|
|
4,380 |
|
|
|
2,107 |
|
||
Other general income(2) |
|
|
(159 |
) |
|
|
— |
|
|
|
— |
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
(159 |
) |
||
Other expense (income), net(3) |
|
|
1,137 |
|
|
|
(346 |
) |
|
|
315 |
|
|
1,851 |
|
|
(395 |
) |
|
|
2,812 |
|
|
|
(2,070 |
) |
||
Stock-based compensation expense(4) |
|
|
32,239 |
|
|
|
2,105 |
|
|
|
2,208 |
|
|
2,820 |
|
|
7,060 |
|
|
|
29,361 |
|
|
|
9,938 |
|
||
Stock-based compensation payroll tax expense(5) |
|
|
305 |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
220 |
|
|
|
305 |
|
|
|
220 |
|
||
LTIP bonus(6) |
|
|
1,369 |
|
|
|
160 |
|
|
|
185 |
|
|
375 |
|
|
489 |
|
|
|
933 |
|
|
|
925 |
|
||
Amortization of inventory step-up(7) |
|
|
4,255 |
|
|
|
— |
|
|
|
— |
|
|
1,711 |
|
|
— |
|
|
|
3,055 |
|
|
|
1,200 |
|
||
Adjusted EBITDA |
|
$ |
75,731 |
|
|
$ |
22,805 |
|
|
$ |
23,731 |
|
$ |
20,741 |
|
$ |
65,128 |
|
|
$ |
53,346 |
|
|
$ |
87,513 |
|
||
Adjusted EBITDA margin(8) |
|
|
16.5 |
% |
|
18.8 |
% |
|
19.0 |
% |
|
18.6 |
% |
|
18.2 |
% |
|
16.0 |
% |
|
|
_________________ | ||
(1) |
Reflects the “Restructuring and transaction costs” line item on our condensed consolidated statement of operations, which primarily includes transaction costs composed of legal and consulting fees, and $1.0 million paid to Kanders & Company, Inc., a company controlled by our Chief Executive Officer, for services related to the acquisition of Cyalume, which is included in related party expense in the Company’s consolidated statements of operations for the year ended December 31, 2022. |
|
(2) |
Reflects the “Other general income” line item on our condensed consolidated statement of operations and includes a gain from a long-lived asset sale. |
|
(3) |
Reflects the “Other (income) expense, net” line item on our condensed consolidated statement of operations and primarily includes gains and losses on foreign currency transactions. |
|
(4) |
Reflects compensation expense related to equity and liability classified stock-based compensation plans. |
|
(5) |
Reflects payroll taxes associated with vested stock-based compensation awards. |
|
(6) |
Reflects the cost of a cash-based long-term incentive plan awarded to employees that vests over three years. |
|
(7) |
Reflects amortization expense related to the step-up inventory adjustment recorded as a result of our recent acquisitions. |
|
(8) |
Reflects Adjusted EBITDA / Net Sales for the relevant periods. |